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Abstract
Objectives To illustrate the clinical and radiological features
of idiopathic interstitial pneumonias (IIPs), according to the
American Thoracic Society (ATS)/European Respiratory So-
ciety (ERS) classification updated in 2013.
Methods IIPs include a subset of diffuse and restrictive lung
diseases, resulting from damage to the parenchyma
characterised by inflammation and fibrosis of the interstitium.
Classification into major and rare IIPs is based on the 2013
ATS/ERS committee.
Results The diagnosis of idiopathic pulmonary fibrosis (IPF)
needs to exclude other well-known causes of interstitial lung
diseases. According to the 2011 evidence-based guidelines,
usual interstitial pneumonia (UIP) can be diagnosed by HRCT
when all criteria are fulfilled. Non-specific interstitial pneu-
monia (NSIP) is characterised by patchy ground-glass opaci-
ties and irregular linear/reticular opacities. The imaging pat-
terns of respiratory bronchiolitis associated-interstitial lung
disease (RB-ILD) and desquamative interstitial pneumonia
(DIP) show centrolobular nodules and ground-glass opacities.
Cryptogenic organising pneumonia (COP) consists of
patchy peripheral or peribronchial consolidations, while
ground-glass opacities are typically associated with diffuse
lung consolidation, evolving to fibrosis, in acute interstitial
pneumonia (AIP). Rare IIPs include lymphoid interstitial
pneumonia and id iopa th ic p leuro -pa renchymal
fibroelastosis (IPPFE).
Conclusions The knowledge of IIP imaging features on
HRCT images help radiologists in diagnosis. Moreover, the
overlap of imaging features needs a multidisciplinary
approach.
Teaching Points
• UIP findings are reticulations, bronchiectasis, honeycombing
and absence of inconsistent features.
• Bilateral patchy ground-glass areas represent the most en-
countered features in NSIP.
• Poorly defined centrilobular nodules are typical of RB-ILD,
whereas a ground-glass appearance is typical of DIP.
• HRCT features of COP include characteristic peripheral or
peribronchial patchy consolidations.
• Rare IIPs include idiopathic LIP and idiopathic pleuro-
parenchymal fibroelastosis (PPFE).
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Introduction
The idiopathic interstitial pneumonias (IIPs) are a group of
acute and chronic diffuse parenchymal lung diseases with
many important features in common. Although all IIPs are
characterised by an unknown aetiology [1, 2], a strong corre-
lation with many factors has already been well established in
the literature [3, 4].
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In 2002 The American Thoracic Society (ATS) and the
European Respiratory Society (ERS) published a classifica-
tion of IIPs [5]. This classification includes usual interstitial
pneumonia (UIP), non-specific interstitial pneumonia (NSIP),
desquamative interstitial pneumonia (DIP), respiratory
bronchiolitis-associated interstitial lung disease (RB-ILD),
cryptogenic organising pneumonia (COP), acute interstitial
pneumonia (AIP) and lymphoid interstitial pneumonia (LIP).
The ATS/ERS Classification has been recently updated,
distinguishing major IIPs from rare IIPs (Table 1). Major IIPs
are grouped into “chronic fibrosing” (IPF and NSIP),
“smoking related” (RB-ILD and DIP) and “acute/subacute”
(COP and AIP). Rare IIPs include idiopathic LIP and idio-
pathic pleuro-parenchymal fibroelastosis (PPFE) [6].
IIPs are generally distinguished from other diffuse paren-
chymal lung diseases on the basis of clinical properties, lab-
oratory tests, physical examination, imaging and histopatho-
logical features [1, 2, 7, 8]. Nevertheless, in some cases it is
very hard to distinguish the condition from other diseases such
as asbestosis, chronic hypersensitivity pneumonitis, autoim-
mune disorders and sarcoidosis [9, 10]. In addition, IIP's
diagnosis should exclude other diffuse lung diseases such as
emphysema or chronic obstructive lung disease, diffuse lung
disease associated with occupational or environmental expo-
sure, lymphangioleiomyomatosis, histiocytosis and eosino-
philic pneumonia [8].
The role of the radiologist in the diagnosis of IIP has being
continuously emphasised in recent years because of the
significant contribution of HRCT in the identification and
diagnosis of diseases. In fact, according to the 2011
evidence-based guidelines, UIP can be diagnosed by HRCT
when all criteria are fulfilled [11].
This pictorial review focusses on the main clinical and
radiological features of IIPs in order to help residents, general
radiologists and clinicians in their diagnosis. However, there is
an overlap of imaging features among IIPs, and a multidisci-
plinary approach is strongly recommended.
Methods
Chronic fibrosing IIPs: UIP and NSIP
Usual interstitial pneumonia (UIP)
Idiopathic pulmonary fibrosis (IPF) is defined as a “specific
form of chronic, progressive, fibrosing interstitial pneumonia
of unknown cause, occurring in adult lungs and associated
with the histopathological and/or radiological pattern of UIP”
[11]. Incidence and prevalence are not easy to estimate be-
cause there were different definitions of IPF [11].
The annual incidence of IPF in the USA is estimated at 6.8–
8.8 per 100,000 [12], while the annual incidence is between
0.22 and 7.4 per 100,000 in the UK [13]. In the USA Coultas
reported that males have a higher prevalence of IPF than
females [14]; Raghu reported a higher IPF prevalence among
Table 1 IIPs classification and their HRCT features
IIPs HRCT features
Major Chronic fibrosing IIPs UIP -Reticular pattern, with or without transaction bronchiectasis
-Honeycombing apperance
-Basal and subpleural predominance
-In “UIP pattern” absence of features listed as inconsistent with UIP
NSIP -Bilateral ground-glass areas
-Reticular opacities
Smoking-related IIPs RB-ILD -Poorly defined centrilobular nodules
-Centrilobular emphysema and/or bronchial wall thickening
DIP -Diffuse ground-glass opacities
-Irregular linear opacities
-Microcyst
Accute/subacute IIPs COP Peripheral or peribronchial patchy consolidations
-Ground-glass opacities with a tendency to migration
Rarely mass or nodules that may cavitate (“atoll sign”)
AIP -Ground-glass attenuation areas with a mosaic pattern
-Air space consolidation in dependent area
Rare LIP -Perivascular cysts and ground-glass opacities
-Centrilobular and subpleuralnodules
PPFE -Subpleural thickening of apital regions
-Small subpleural consolidations
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older males (>65 years), and a similar trend has been observed
in European studies too [12]. A higher prevalence is observed
in patients >75 years of age [12, 15].
Comparative epidemiological data of different interstitial
lung diseases (ILDs) are limited to a few studies, which
suggest that sarcoidosis and IPF are the most frequent ILDs
followed by hypersensitivity pneumonitis and ILD in collagen
vascular disease [16].
For a long time IPF has been considered the result of a
chronic inflammatory process that evolves in fibrosis. Cur-
rently, a hypothesis based on the presence of an inflammatory
process has been has been abandoned and the “epithelial-
fibroblastic route” proposed instead to explain disease devel-
opment [17]. It consists of a pathological interaction between
the pulmonary epithelium and mesenchyme. An initial “noxa
patogena” causes injury to alveolar epithelial cells, with their
apoptosis. The release of growth factors and chemokines leads
to the migration of mesenchymal cells throughout the dam-
aged basement membrane, creating fibroblastic foci (activated
fibroblast-myofibroblast). Myofibroblasts secrete extracellu-
lar matrix proteins, providing a provisional matrix that serves
as the scaffold for normal tissue repair. To reach a correct
healing formation, myofibroblasts should undergo apoptosis.
Failure of apoptosis is typical of IPF, leading to myofibroblast
accumulation, exuberant extracellular matrix production and
pathological scar formation. A recent hypothesis proposes IPF
as a neoproliferative disorder of the lung. Genetic alterations,
response to growth and inhibitory signals, resistance to apo-
ptosis, altered cellular communications and intracellular sig-
nalling pathways are hallmarks common to IPF and cancer
[18].
Histologically the disease is characterised by scattered
fibroblastic foci with heterogeneous distribution that alternate
interstitial inflammation and honeycombing. These findings
coexist with normal lung areas. The prognosis of UIP is
variable. In fact, the disease is influenced by the extent of
the disease and the severity of functional impairment at the
time of diagnosis [11].
Radiological features
Imaging findings on a chest X-ray are not specific (Fig. 1).
Reticular pattern and bronchiectasis, involving predominantly
lower lobes and costophrenic angles, are generally recognised.
Unfortunately, imaging findings could be misdiagnosed in the
early stage of disease.
Typical HRCT features are represented by a reticular pat-
tern, traction bronchiectasis and honeycombing appearance
(Figs. 2 and 3). These imaging findings are predominantly
located in the subpleural regions and in lower lobes.
On HRCT, the most important imaging feature is the
honeycombing, which consists of a cluster of cystic air spaces,
usually with a diameter of 3–10 mm, although they may reach
2.5 cm in size (Figs. 4 and 5) [19, 20]. The honeycombing is
considered the most specific sign of UIP [19]. HRCT shows
enlargement of mediastinal lymph nodes in 70–80 % of cases.
The nodes are typically encountered in the paratracheal areas
[10].
Traction bronchiectasis is frequently encountered among
IIPs, very often reproducing a micro- or macrocystic appear-
ance that is difficult to differentiate from honeycombing. The
use of multiplanar reconstructions (MPR) is strongly recom-
mended for distinguishing between honeycombing and a
cluster of cystic bronchiectasis.
The diagnosis of UIP is essentially based on HRCT and
histological appearance [11].
Three main patterns have been distinguished: “UIP
pattern”, “possible UIP” and “inconsistent with UIP. The
UIP pattern (Fig. 3) is characterised by all four features of
the disease, which include: (1) basal and subpleural predom-
inance; (2) reticular pattern, with associated traction
Fig. 1 Chest X-ray in a 57-year-old man with UIP. Imaging findings are
not specific and reticular pattern in the early stage of disease is not
appreciable
Fig. 2 HRCT image of a UIP pattern (same patient of Fig. 1). Typical
imaging features of UIP are clearly recognisable because of the presence
of honeycombing (black arrows), traction bronchiectasis (white arrow)
and a reticular pattern (black dotted arrows). Lesions are typically located
along subpleural regions
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bronchiectasis; (3) honeycombing appearance; (4) absence of
features listed as inconsistent with a UIP pattern [11].
The possible UIP pattern (Fig. 6) includes: (1) reticular
pattern again—with or without traction bronchiectasis; (2)
the presence of a typical gradient (lower lobes and subpleural
localisation of disease); (3) no features listed as inconsistent
with a UIP pattern. The most specific sign of UIP, the
honeycombing appearance, is not recognisable.
Finally, the pattern “inconsistent with UIP” (Fig. 7) in-
cludes the presence of any of the following features: upper
or mid-lung predominance; peribronchiovascular predomi-
nance; extensive ground-glass abnormality; profuse
micronodules; discrete cysts; diffuse mosaic attenuation/air-
trapping; parenchymal consolidations.
These three patterns need to be related with histological
appearances of IPF, even though the role of HRCT is a crucial
element in the diagnosis. Matching the three patterns reported
with histological results, we have to underline the following
innovations:
(1) The UIP pattern does not need to be confirmed by
histology. HRCT after the exclusion of identifiable
causes of ILD allows for the diagnosis of IPF, even if
surgical lung biopsy is possible, probable or non-
classifiable [11].
(2) The possible UIP pattern needs to be correlated with
biopsy. Cases with a possible UIP pattern on HRCT
and UIP or probable histological UIP pattern allow for
the diagnosis of IPF;
The diagnosis of IPF is graded as “possible” when we
identify one of the features listed as inconsistent with UIP
and surgical lung biopsy obtains a pattern of UIP [11].
Non-specific interstitial pneumonia (NSIP)
The introduction of NSIP among IIPs was made by
Katzenstein and Myers in 1998. Several studies have been
focussed on the fact that some cases of interstitial pneumonias
did not match with UIP, DIP or AIP on the basis of the
histopathological features [21]. These pneumonias have been
reported as “non-specific interstitial pneumonias” by Travis
et al. [21, 22].
NSIP is less common than UIP, but is still one of the most
common interstitial pneumonias. Its incidence is unknown,
Fig. 3 “UIP pattern”. A UIP
pattern is characterised by all the
following features: (1) basal and
subpleural predominance (black
arrows); (2) reticular pattern
(black arrows), with associated
traction bronchiectasis (white
arrowhead); (3) honeycombing
appearance (black dotted arrow);
(4) absence of features listed as
inconsistent with the UIP pattern
Fig. 4 Honeycombing appearance on HRCT images. The cystic spaces
reproduced on HRCT images (A and C); a real honeycomb (B, removed
from apartment window of one of the authors). The honeycombing
appearance consists of a cluster of cystic air spaces, usually with a
diameter of 3–10 mm, although they may reach 2.5 cm in size [19, 20]
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with different reports ranging from 14 to 36 % of all IIPs
[5, 23].
The histopathological and radiological pattern of NSIP is
reproduced in a wide variety of lung diseases, and this is the
reason why some authors in the literature have debated con-
sidering this disease an independent clinical entity [24].
However, the revision 2002 ATS/ERS IIPs statement clas-
sifies idiopathic NSIP as a specific clinicopathological entity
[6].
“The clinical diagnosis of NSIP”—as reported by
Romagnoli et al.—“should be reserved only for idiopathic
and biopsy-proven cases when no causative factor can be
Fig. 5 Variable degrees of honeycombing appearance. HRCT images in
three different UIP patients, with variable degrees of honeycombing
representation. Image A shows a subpleural reticular pattern and small
honeycombing area. The diagnosis of UIP was also successfully con-
firmed by histological biopsy. Patient DLCO was 89 % at the time of
diagnosis. In a second patient (B), with respiratory insufficiency and
severe reduction of DLCO (39 %), the UIP pattern was again diagnosed
by CT examination. C and D show diffuse honeycombing, which mas-
sively involves the basal regions of lower lobes. The patient in C andD, at
the time of clinical examination, was a smoker of 40 pack/years, with
progressive dyspnoea and productive cough for 2 years. Pulmonary
function tests showed lung failure and severe DLCO reduction (30 %)
with obstructive spirometric pattern
Fig. 6 “Possible UIP” pattern in a 77-year-old man. The possible UIP
pattern includes: (1) reticular pattern (black arrows), with or without
bronchiectasis (curved black arrows); (2) the presence of a typical
subpleural location (black arrows); (3) no features listed as inconsistent
with the UIP pattern
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identified” [25]. NSIP has been divided into either idiopathic
NSIP [5]—when the disease is not related to another under-
lying disease—or secondary NSIP, which occurs in cases
where it is possible to identify a known aetiology [26]. Several
articles in the literature describe the associations between the
radiological appearance of NSIP and autoimmune disorders
[27, 28].
Histologically, NSIP is characterised by temporally uni-
form interstitial changes in the lung, whereas UIP is typi-
cally heterogeneous in the temporal distribution of fibrosis
[29]. NSIP, as reported in a paper by Schaefer and
Prokop—“shows a temporary more uniform histological
picture in the way that parenchymal changes appear to
have occurred over a single relatively narrow time span”
[10]. Histologically, considering the variable amounts of
fibrosis and inflammatory components, Travis et al. distin-
guished a “cellular NSIP” and a “fibrosing NSIP”. Here,
the cellular type is characterised by chronic interstitial
inflammation with poor fibrosis, while the fibrosing NSIP
shows preservation of the alveolar architecture and inter-
stitial thickening due to fibrosis [30].
The distinction between cellular and fibrosing NSIP has a
prognostic implication. Travis et al. revised more than 100
biopsies including UIP, cellular NSIP, fibrosing NSIP and
DIP. The survival rate at 5 and 10 years for patients with
histologically proven cellular NSIP, fibrosing NSIP and DIP
was higher than in patients with idiopathic UIP [22]. In
addition, analysing the 5- and 10-year survival rates, they
discovered a significant difference between cellular and fibro-
sis types of NSIP, with a better course observed for cellular
NSIP [22].
Mainstream treatment is based on corticosteroids. Among
patients treated with corticosteroids—when reduction of the
dose is not able to avoid collateral effects—a possible resource
could be an additional nonsteroidal immunosuppressive
agent.
Radiological features
Considering the different prognosis between UIP and
NSIP, radiologists need to carefully evaluate the most
important imaging features in the differentiation between
UIP and NSIP.
Imaging findings on a chest X-ray are not specific, with
infiltrates predominantly located in the lower lobes, a reticular
pattern and bronchiectasis.
HRCT features (Figs. 8 and 9) include [7, 31, 32]:
– bilateral ground-glass areas in the lung, sometimes with
extensive distribution;
– reticular opacities, which can be superimposed on a
ground-glass pattern;
– traction bronchiectases, which can be parallel in their
course through the lungs or extremely irregular.
Bilateral patchy areas of ground glass, predominately lo-
cated in the middle and lower lung, represent the most en-
countered features in NSIP, with or without traction bronchi-
ectasis or reticulation. Honeycombing is a rare sign among
NSIPs [33–35]. Lower lobe volume loss and subpleural areas
not involved by ground-glass opacifications (Fig. 10) are other
CT features observed [30].
However, in a series of 50 patients studied by Hartmann,
the typical pattern of NSIP described—bilateral patchy
ground-glass areas—was found only in 22 % of cases; 32 %
of patients showed pulmonary alterations compatible with a
UIP pattern, and in the remainder of cases the imaging ap-
pearance was considered non-diagnostic or more compatible
with other chronic infiltrative lung diseases [33, 36]. This
variability of imaging presentation correlates with the hetero-
geneous histological appearance of NSIP. Some authors have
previously reported that some cases of NSIP are reported as a
“diagnosis of exclusion” in patients who have histological
Fig. 7 Pattern “inconsistent with UIP”. “Inconsistent with UIP” patterns
in two HRCT images respectively found in a 75-year-old woman (A) and
a 57-year-old man (B). Cystic spaces along peribronchovascular bundles
(A) and parenchymal consolidations (B) are well demonstrated. However,
UIP diagnosis was formulated in the histological reports in both cases
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findings not typical of AIP, UIP or COP. These patients have
variable degrees of interstitial inflammation and fibrosis, focal
areas of COP, prominent inter-alveolar macrophages and
peribronchial accentuation of infiltrates [36]. This heteroge-
neous appearance—with many features of COP, UIP and
DIP—explain the variability on imaging [36].
A honeycomb-like appearance could be simulated by ir-
regular traction bronchiectasis. Use of coronal reformatted
images helps to easily distinguish between the ectatic cystic-
like changes of the bronchi and the true cysts of typical
honeycombing [37]. Differential diagnoses include several
chronic infiltrative diseases, such as extrinsic allergic alveoli-
tis, UIP, DIP and AIP.
Smoking-related IIPs: RB-ILD and DIP
Respiratory bronchiolitis with associated interstitial lung
disease (RB-ILD)
RB-ILD has been defined as the “clinical manifestation of
interstitial lung disease associated with the pathological lesion
of RB” [5]. The first description of smoking-related
Fig. 8 NSIP pattern in a 64-year-
old man. HRCT features of NSIP
include extensive ground-glass
areas in the lung (black arrows)
and traction bronchiectasis. This
bronchiectasis frequently shows a
parallel course through the lung,
well depicted by sagittal
reconstruction in D (black dotted
arrows). There is no
honeycombing in the lung. Cystic
bronchiectasis is generally well
documented by MPR images
Fig. 9 NSIP pattern. Typical NSIP pattern in a 78-year-old woman, consisting of ground-glass areas, sometimes superimposed on a reticular pattern, and
traction bronchiectasis
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bronchiolitis was reported in 1974, when Niewoehner dem-
onstrated the presence of clusters of pigmented macrophages
in respiratory bronchioles and neighbouring alveoli of
smokers [38]. Myers et al. observed similar alterations—re-
spiratory bronchiolitis—in patients with clinical and radiolog-
ical features of chronic interstitial lung diseases [39]. The
clinicopathological syndrome of RB-ILD was subsequently
introduced by Youseum et al. [40].
The histological reports described by Niewoehner—
pigmented macrophages in respiratory bronchiolitis [38]—
represent a specific response to smoking. In some patients,
bronchiole inflammation and intra-alveolar accumulations of
pigmented macrophages cause the development of clinical
and radiological ILD.
Fraig et al. demonstrated the presence of RB in all smokers
and about 50 % of former smokers [41]. It generally affects
smokers of 30–40 years of age with a history of more than 30
pack-years of cigarette smoking [42, 43]. The disease has a
slight male predominance [44]. The most encountered clinical
symptoms are cough and dyspnoea. Inspiratory crackles are
found in about 50 % of cases, whereas digital clubbing is rare
[45].
The histological hallmark of RB-ILD is represented by the
accumulation of alveolar macrophages within respiratory
bronchioles. Macrophages are characterised by eosinophilic
cytoplasm, with brown granular pigmentation representing
constituents of cigarette smoke. It is also possible to observe
a chronic inflammatory cell infiltrate within bronchiolar walls,
while no honeycomb change or fibroblastic foci are present.
Myers and colleagues suggested that the main difference
between RB and RB-ILD is based on the extent of the
fibrosing and inflammatory process that in RB-ILD involves
also adjacent alveolar walls [39].
A number of studies that have linked smoking with the
insurgence of RB-ILD have demonstrated a clear improve-
ment of the disease after smoking cessation. Nakanishi et al.
have shown that smoking cessation alone, without any other
treatment, leads to clinical, functional and radiographic im-
provement [46]. Symptoms and DLCO values were both
improved after smoking cessation as well as ground-glass
opacities and centrilobular nodules on CT scans. However,
some studies have not confirmed the effectiveness of smoking
cessation and have also investigated the role of other treat-
ments such as steroids or immunosuppressant drugs; Portnoy
et al. described a clinical and functional decline in 32 patients
with RB-ILD, in spite of smoking cessation and steroid treat-
ment [47]. However, the real effectiveness of smoking cessa-
tion, corticosteroids or immunosuppressants in the treatment
of RB-ILD remains a clinical dilemma and needs to be further
evaluated.
Radiological features
Normal chest X-ray has been described in up to 20–30 % of
cases [48]. Non-specific signs often detected are represented
by thickening of the central and peripheral wall of bronchi and
ground-glass areas [42, 49]. Other possible pattern feature on
chest X-ray could be the presence of reticular-nodular opaci-
ties with upper lobe predominance or diffuse distribution.
Main HRCT features (Fig. 11) are [50]:
– ground-glass opacities (correlated with macrophage ac-
cumulation in alveolar spaces);
– poorly defined centrilobular nodules (due to
peribronchial extension of intraluminal infiltrate), also
indicated as centrilobular ground-glass nodules (Fig. 11).
– diffuse lung distribution;
– other main CT features: centrilobular emphysema and/or
bronchial wall thickening due to cigarette smoking and
frequently encountered in RB-ILD patients (Fig. 11) [7, 8,
42].
A small number of patients show a reticular pattern due to
fibrosis in the absence of traction bronchiectasis and
Fig. 10 HRCT features of NSIP. NSIP patterns are shown in a 52-year-
old woman (A) and in a 75-year-old woman (B). Bilateral patchy ground-
glass areas, predominantly located in the middle and lower areas, repre-
sent the most important HRCT feature of NSIP. However, when the
ground-glass area is not extensively distributed through the lungs, the
differential diagnosis from the UIP pattern remains very difficult.
Subpleural areas not involved by ground-glass opacifications (black
arrows) have been suggested as other CT features helpful for diagnosis
[30]
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honeycombing [43, 44, 49]. Differential diagnosis includes
acute hypersensitivity pneumonitis, NSIP and DIP [44].
Desquamative interstitial pneumonia (DIP)
The term “desquamative interstitial pneumonia” was in-
troduced by Liebow, who believed that intra-alveolar
cells, typical of this disease, were reactive alveolar
pneumocytes “desquamated” from the alveolar surface
[51]. Later, electron microscopy demonstrated that these
cells were alveolar macrophages, even though the defi-
nition of “desquamative interstitial pneumonia” is cur-
rently considered a form of interstitial pneumonia
characterised by the presence of diffuse exudation of
pigmented macrophages in the alveolar spaces [6]. Some
studies have proposed DIP as the cellular phase of UIP
because of some similarities in histopathological features,
but this idea was not sustained by Carrington et al.
because of the poor prognosis for UIP and the absence
of response to corticosteroid therapy in comparison with
DIP [52].
The correlation between cigarette smoke and DIP has been
proved in different studies, showing that almost 90 % of
patients affected by DIP are current or former smokers. Based
on a comprehensive evaluation of HRCT findings, Heyneman
et al. hypothesised that DIP and RB-ILDmay be considered as
different degrees of severity of a reaction of small airways and
lung parenchyma to cigarette smoke [49]. It is important to
note that DIP has also been associated with a variety of other
conditions including drug reactions and connective tissue
diseases such as scleroderma [53], lupus [54] and rheumatoid
arthritis [55]. Very few epidemiological data regarding DIP
are present in the literature, probably linked to the poor
knowledge of the disease. According to Carrington et al.,
DIP accounts for less than 3 % of interstitial lung diseases,
commonly affecting patients in their third to fifth decade, with
a preference for males, who are affected nearly twice as often
as females [52].
Even though the criteria to differentiate histological
patterns of DIP from RB-ILD are well defined [6], the
histopathological diagnosis of DIP is difficult because of
the similarities to RB-ILD. According to this classifica-
tion, DIP is characterised by macrophage accumulation
in the distal air spaces with alveolar pneumocyte prolif-
eration along the alveolar septa. The thickening of al-
veolar septa is also due to a chronic inflammatory
infiltrate that includes eosinophils and lymphoid aggre-
gates. However, the histological differential diagnosis
between DIP and RB-ILD is based on the extension of
lesions. DIP affects the lung in a more uniform manner,
while RBILD lesions have a bronchiolocentric distribu-
tion [49].
Radiological features
Chest radiographs may show bilateral interstitial infiltrates
(hazy opacities) but this pattern is non-specific for detection
of DIP.
Pathognomonic radiological features of DIP are well stud-
ied through HRCT scans (Figs. 12 and 13). They are repre-
sented by:
– Diffuse ground-glass opacities (Figs. 12 and 13), corre-
lated histologically with the spatially homogeneous intra-
alveolar accumulation of macrophages and thickening of
alveolar septa: bilateral and symmetric (86 %), basal and
peripheral (60 %), patchy (20 %) and diffuse (20 %) [8,
56, 57].
– Irregular linear opacities.
– Microcysts (50 % of patients) [7] (Fig. 12).
However, ground-glass opacification of the lung is the
most important imaging feature of DIP. Differential diagnosis
generally includes chronic hypersensitivity pneumonia and
RB-ILD.
Fig. 11 RB-ILD pattern in a 52-year-old smoker patient. Poorly defined
centrilobular nodules (white arrows), due to peribronchial extension of
the infiltrate, are uniformly disseminated through the upper lobes. Other
CT features very frequently encountered are centrilobular emphysema
(white arrowhead)
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Acute/subacute IIPs: COP and AIP
Cryptogenic organising pneumonia (COP)
Descriptions of this clinical entity first appeared in the latter
half of the nineteenth century, notably in a lecture by J.M.
Charcot in Paris in 1877–1878 [58]. Milne described a pneu-
monia “where the usual process of resolution has failed and
organisation of the inflammatory exudate in the air alveoli of
the lung by fibrous tissue has resulted” [59]. COP is a well-
established entity known since the 1950s. However, at the
beginning, it was considered a pulmonary condition caused by
chronic persistence of a pneumonitis.
COP has also been called idiopathic bronchiolitis
obliterans organising pneumonia (BOOP). This term was
described for the first time by Davidson in 1983, but was
changed to avoid confusion with constrictive bronchiolitis
obliterans, which is an airway disease [60]. Actually, the
term COP is preferred because its clinical, physiological
and imaging features are unrelated to bronchiolar obliter-
ation [1].
COP still is included in the classification of IIPs published
by Travis et al. [6] in view of its idiopathic nature. Sometimes
it is possible to identify an underlying disease, so the sentence
“OP associated to” is generally suggested [6].
The mean age of patients affected by COP is 55 years.
There is no gender predilection. COP is not associated with
cigarette smoking. In fact, most patients are nonsmokers or
ex-smokers. Histopathologically it is characterised by the
accumulation of granulation tissue lying within small airways,
alveolar ducts and alveoli [61]. In particular, the intra-alveolar
granulation tissue consists of intermixed myofibroblasts, fi-
broblasts and connective matrix [62]. The intra-alveolar buds
in COP may resemble some histopathological features of
fibroblastic foci of usual interstitial pneumonia, but differently
the myofibroblasts do not show progression to irreversible
fibrosis [62]. The origin of these myofibroblastic cells has
already been debated in several articles. Some recent studies
have shown that myofibroblasts are not resident in the pulmo-
nary interstitium, but they derive from bone marrow [63].
The main clinical features include subacute onset of cough,
fever, dyspnoea and sparse crackles at auscultation [64].
Radiological features
Imaging findings of COP have already been described; it can
be observed in three main patterns: the typical form, due to the
presence of multiple alveolar opacities; the form with focal
consolidation, also called focal COP; the infiltrative form,
characterised by the presence of infiltrative opacities.
Fig. 12 DIP pattern in a 60-year-old man. The patient (smoker of 25
pack-years) complained of progressive dyspnoea and dry cough. Pulmo-
nary function was characterised by a moderate reduction in DLCO and
normal dynamic lung volumes. Physical examination revealed digital
clubbing and fine crackles were heard in the lung bases on chest auscul-
tation. On HRCT images, lung ground-glass opacifications are clearly
shown through the lungs and correlate with the intra-alveolar accumula-
tion of macrophages. Bronchial wall thickening and bronchiectasis are
also associated. Microcysts have been described in almost 50 % of cases
[7]. The coronal HRCT image (C) clearly shows peribronchovascular
small cysts (white arrow); also emphysema is recognisable through the
lung
Fig. 13 DIP pattern. A 54-year-
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On a chest X-ray, the typical appearance consists of multi-
ple bilateral patchy areas of consolidations [61]. These con-
solidations are due to the presence of granulation tissue at the
alveolar spaces. Typically, these alveolar infiltrates could mi-
grate to different lung areas on different chest X-rays.
HRCT features of COP are more extensive than chest
radiographs and include:
– characteristic peripheral or peribronchial patchy consoli-
dations (sometimes with subpleural area spread), also
with air bronchograms and mild cylindrical bronchial
dilatation (Fig. 14);
– increase of consolidations over several weeks after anti-
biotic therapy;
– ground-glass opacities with tendency to migration,
change of location and size;
– rarely a mass or nodule that may cavitate or reproduce the
typical appearance of an “atoll sign” (Fig. 15);
The “atoll sign” is due to the presence of a ring consolida-
tion surrounding normal lung or ground-glass opacification. It
is considered relatively specific for OP as it is found in 20% of
patients with COP. However, the atoll sign has also recently
been described in other conditions such as sarcoidosis and
Wegener’s granulomatosis [65–67]. HRCT shows multiple
consolidations or nodules distributed in sub-pleural areas or
along the bronchovascular bundles [61, 68, 69].
Acute interstitial Pneumonia (AIP)
AIP is severe and sudden in onset, progressing rapidly [70].
The disease has been reported by Hamman and Rich, describ-
ing for the first time “four cases of a rapidly progressive
disease pathologically characterised as extensive pulmonary
fibrosis” [71, 72]. Katzeinstein reported other cases very
similar to those observed by Hamman and Rich and in 1986
introduced the term AIP for these “rapid interstial lung dis-
eases” [73].
AIP represents an idiopathic disease, which occurs more or
less equally in men and women, with a mean age of 50 years
[7, 74, 75]. It usually occurs in previously healthy people,
although often the patients present with symptoms suggestive
of a viral upper respiratory infection, such as myalgia, arthral-
gia and fever. Smoking might not increase the risk of devel-
oping AIP.
Most patients develop severe dyspnoea within 3 weeks of
the onset of symptoms and seek medical attention with signs
of pneumonic consolidation with diffuse crackles [5, 7, 74]. A
restrictive pattern with reduced diffusing capacity is typical in
pulmonary function tests. The condition rapidly progresses to
acute respiratory failure, which requires mechanical ventila-
tion, with oxygen supplementation.
Diagnostic clinical criteria for acute respiratory distress
syndrome (ARDS)—consisting of acute onset, a PaO2/FIO2
(fraction of inspired oxygen ratio) equal to or less than
200 mmHg, diffuse bilateral opacities on chest radiograph,
and a pulmonary capillary wedge pressure of less than
18 mmHg or no clinical evidence of left atrial hyperten-
sion—are often fulfilled [73, 75, 76].
In the early phase of disease, corticosteroid therapy seems
to be useful. The prognosis of AIP is poor and death occurs in
Fig. 14 COP pattern in a 53-
year-old man. HRCT images
show characteristic peripheral and
bronchocentric consolidations.
The “air bronchogram sign” is
clearly recognisable in A.
Tendency to migration and
changing location are also typical
imaging findings of COP
Fig. 15 An “atoll sign” in a 69-year-old female. Black arrows show
circular consolidations surrounding normal parenchyma
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50 % or more of cases 1–2 month after illness onset; the
patients who survive the acute phase of the disease later
develop lung fibrosis [74].
The histological hallmark of AIP is diffuse alveolar dam-
age with the same appearance of acute respiratory distress
syndrome caused by sepsis and shock. In fact, AIP is consid-
ered an idiopathic form of ARDS [72, 77]. The alveolar
damage can be classified into an early exudative phase and a
late organising phase, based on the timing between lung insult
and biopsy [6, 7].
AIP in the exudative phase is characterised by interstitial
and intra-alveolar oedema, hyaline membranes and diffuse
alveolar infiltration by acute inflammatory cells. In the
organising phase, generally at the end of the first week after
lung injury, granulation tissue, with alveolar wall thickening,
organising fibrin and fibrosis within alveolar lumens and
thrombi in small and medium-sized pulmonary arterioles,
are visible [7, 72, 78].
Sometimes, the lung architecture may be partially restored,
while in other cases, the lungs develop extensive honeycomb
fibrosis, which is uniform with numerous fibroblasts and little
collagen deposition, different from the heterogeneous appear-
ance of UIP.
The histopathological pattern is necessary for a definitive
diagnosis [7]. Sometimes, ill patients are unable to tolerate
surgical lung biopsy and a transbronchial biopsy is performed
[7, 79].
Radiological features
Chest radiography in AIP shows bilateral airspace
opacifications with air bronchograms, which usually spare
the costophrenic angles [80]. The lung volume may be lower
than normal. Consolidations often becomemore diffuse and in
progression to the organising stage the radiograph shows a
ground-glass appearance with irregular linear opacities.
On HRCT images (Fig. 16), AIP is characterised by diffuse
ground-glass attenuation areas with a mosaic pattern, resulting
from the presence of alveolar septal oedema and hyaline
membranes, and airspace consolidation in dependent areas
of the lung, reflecting the intra-alveolar oedema and haemor-
rhage; these features are seen in the exudative phase [7, 74, 80,
81]. These signs are usually bibasilar, but often can be diffuse
or involve upper lobes [74]. Consolidations, caused by intra-
alveolar fibrosis, are seen in the organising phase,
characterised by lung architectural distortion, traction bron-
chiectasis and cysts [74, 80–83]. These findings are more
severe in the nondependent areas of the lung, because of the
“protective” effect of atelectasis and consolidation on the
dependent areas of the lung in the exudative phase to attenuate
the potential injury related to mechanical ventilation [7, 74,
84]. Patients who survive show areas of hypoattenuation, lung
cysts, reticular abnormality and associated parenchymal dis-
tortion often in the nondependent lung.
Other differential diagnoses are widespread infection such
as Pneumocystis carinii pneumonia, DIP, hydrostatic oedema,
haemorrhage, alveolar proteinosis and bronchioloalveolar cell
carcinoma.
Ground-glass attenuation at HRCT usually evidences the
presence of potentially reversible disease. Several studies have
shown that in AIP areas of ground-glass attenuation and
consolidation are visible in all histological phases, reflecting
different histological findings, so they are not helpful in
predicting the underlying histology [77, 81, 85]. The associ-
ation of ground-glass attenuation, consolidation and traction
bronchiectasis correlates with the fibrotic phase [77]. Histo-
pathological examination is essential and diagnosis should be
made after the revision of all clinico-radiological-pathological
data.
Rare IIPs: idiopathic LIP and idiopathic pleuroparenchymal
fibroelastosis
Lymphoid interstitial pneumonia (LIP)
LIP was first described by Liebow and Carrington in 1969 in
relationship with diffuse lymphocytic infiltrates in the inter-
stitium, different from other patterns of interstitial pneumonia
[86–88]. At the beginning it was included in the main classi-
fication of IIPs edited by Liebow, but many years later it was
removed. Some authors in fact assert that it should be classi-
fied among pulmonary lympho-proliferative diseases and not
with interstitial pneumonias, because it appears in patients
with lymphoma [87, 89–91]. It was also considered a
preneoplastic condition, progressing to malignant lymphoma
in up to 30 % of cases [74, 87].
In recent years both ATS and ERS have once more classi-
fied LIP among IIPs, because it often remains of unknown
origin [5, 87].
LIP is rare and it is often associated with systemic disease
such as Sjögren's syndrome (25% in patients with LIP), AIDS
(particularly children), immunodeficiency syndromes
(Castleman's disease) and autoimmune thyroid disease; these
disorders should be investigated when this pattern is histolog-
ically found [1, 74, 87, 91]. When other underlying diseases
are definitively excluded, a diagnosis of idiopathic LIP could
be defined [5].
LIP usually affects women and it is typically diagnosed
during the fifth decade of life [87]. Onset of the symptoms is
often slow, with patients complaining of a gradually progres-
sive cough and dyspnoea over 3 or more years. Sometimes,
systemic symptoms, such as fever, weight loss, chest pain,
night sweats and arthralgia, are also reported [87]. LIP rarely
progresses to fibrosis, so crackles, digital clubbing and phys-
iological features of other IIPs are unusual [87, 88]. This
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pneumonia often shows symptoms of the underlying systemic
or autoimmune disease, such us lymphadenopathy in the
presence of Sjögren’s syndrome. Respiratory symptoms help
to detect lung involvement.
Laboratory investigations can detect mild anaemia and
dysproteinaemia as a polyclonal increase in gamma globulin
or a monoclonal increase in IgG or IgM (approximately in
80 % of patients with LIP). The risk of a lymphoproliferative
malignancy increases in patients with a monoclonal
gammopathy or hypogammaglobulinaemia [74, 87].
Bronchoalveolar lavage fluid shows numerous lympho-
cytes, without any clonality at immunophenotyping.
Histologically, LIP seems to be a histological variant of
diffuse pulmonary lymphoid hyperplasia primarily affecting
the interstitium. It is characterised by lymphoid infiltration of
the interstitium with lymphocytes, plasma cells and histio-
cytes, which lead to progressive widening of alveolar septa
[74, 87, 94–96]. The airspace may be secondarily affected by
interstitial infiltrates, proteinaceous fluid and macrophage ac-
cumulation. Reactive lymphoid follicles are often present
along inflamed peribronchiolar areas; nonnecrotising granu-
lomas and honeycombing in advanced cases may also be seen
[74]. LIP must be differentiated from follicular brochiolitis, a
peribronchiolar lymphocytic infiltrate with germinal centres.
The treatment of LIP consists of corticosteroids. Therapy
response is uncertain as many patients present an arrest or
improvement in symptoms and more than one-third progress
to diffuse interstitial fibrosis. Death often occurs because of
infections associated with immunosuppression, progressive
pulmonary fibrosis, or transformation to malignant
lymphoma.
Radiological features
HRCT images usually demonstrate diffuse or predominantly
lower bilateral abnormalities. They also show the presence of
lymphatic nodes, normally seen in patients with LIP [87]. LIP
is most severe in the inflamed perilymphatic interstitium, so
thickening of the bronchovascular bundles and interlobular
septa is usual [94]. Uniform or patchy areas of bilateral
ground-glass opacity are typical findings in LIP and they
reflect the histological evidence of diffuse interstitial inflam-
mation [92, 95].
Other findings (about 80 % of cases) are a few,
perivascular, thin-walled cysts (Fig. 17) [74, 94]. These cysts
measure 1–30 mm and are seen within the lung parenchyma,
predominantly in the mid-lung zones, adjacent to blood ves-
sels (in UIP, cysts are usually subpleural and in lower lung
Fig. 16 AIP pattern in a 56-year-old man. The patient was admitted to
our emergency room for severe dyspnoea (leukocytes=12,000/mmc;
neutrophils 90 %; D-dimer 452 ng/ml; CRP 7,10 mg/dl; ERS 78 mm/
h). CT images show mild pleural effusion, ground-glass opacifications
and inhomogeneous consolidations. Differential diagnosis includes sev-
eral diseases, such as acute exacerbations of IIPs, NSIP, COP, infectious
diseases and collagen-related lung fibrosis
Fig. 17 Pattern of LIP. Small thin-walled cysts (white arrows) represent a
typical imaging feature of LIP, usually not exceeding 30 mm and located
in the mid-lung zones, adjacent to blood vessels. A partial “check-valve”
bronchiolar obstruction has been considered the main explanation for cyst
formation. The bronchiolar obstruction—due to lymphoid nodules and
aggregates—leads to “air trapping”
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areas) [97, 98]. A partial “check-valve” bronchiolar obstruc-
tion has been considered as the main explanation for cyst
formation because the bronchiolar obstruction due to the
lymphatic infiltration leads to a consequent partial air trapping
[97, 98].
The association of perivascular cysts and ground-glass
opacities is highly suggestive of LIP.
Centrilobular and subpleural nodules (Fig. 18) with thick-
ening of the interlobular septa are also typical and reflect the
inflammatory infiltration of the peribronchiolar interstitium
[92]. Perivascular honeycombing in areas of previous airspace
abnormality and reticular pattern (in about 50 % of patients)
can also be seen.
Regarding the differential diagnosis, the HRCT pattern of
LIP should be differentiated from hypersensitivity pneumoni-
tis, sarcoidosis and lymphangitic spread of tumour.
Pneumocystis carinii pneumonia may be considered because
of cystic abnormalities. A very important differential diagno-
sis is from Hodgkin’s lymphoma [99].
Pleuroparenchymal fibroelastosis (PPFE)
Idiopathic PPFE has been recently included in the ATS/ERS
IIPs classification [6] as a rare IIP. However, it was described
by Amidani et al. in the Japanese literature as idiopathic
pulmonary upper lobe fibrosis [100, 101].
It is a characterised by the development of fibrosis along
pleural surfaces and subpleral parenchymal lung, with pre-
dominantly upper lobe involvement.
Some clinical data report an association between recurrent
pulmonary infection and development of PPFE.Many authors
have recently reported PPFE as a pulmonary reaction associ-
ated with chronic graft-versus-host disease following bone
marrow transplantation [102]. Some histopathological pat-
terns of PPFE have been interpreted as little spontaneous
pneumothoraces followed by an obliterative pleural reaction
and subpleural fibrosis [102].
In a PPFE series reported by Reddy et al. a male/female
ratio of 1/1.4 was found, whereas in the literature the tendency
is a male/female ratio of 2/1 [101].
Histologically, the hallmarks consist of pleural thickening
and subpleural fibrosis.
Radiological features
Chest X-ray shows aspecific pleural thickening of apical
regions, with small subpleural pulmonary consolidations. This
imaging pattern is indistinguishable from many other chronic
pulmonary infections (tuberculosis). Superior hilar retraction
has been described in all five cases reported byKusagaya et al.
[103].
Fig. 18 Pattern of LIP (after
corticosteroid treatment). Small
reticular opacities and nodules
(black arrows) are well depicted
in the caudal area of the right
upper lobe. Surgical biopsy
revealed reactive lymphoid
follicles along peribronchial
regions and indicated a LIP
diagnosis
Fig. 19 IPPFE pattern in a 57-
year-old woman. Pleural
thickening and subpleural
consolidations (black arrows) are
well recognisable in the upper
lobes. Sometimes pleural
thickening involves the lobar
fissure (black arrow in A).
Bronchiectases are also
encountered (black curved arrow)
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HRCT (Fig. 19) shows pleural thickening in the upper
pulmonary zones, sometimes also associated with other signs
of fibrosis, such as bronchiectasis. Subpleural consolidations
and/or reticulations are well depicted in the upper and middle
zones. Pleural irregularities could extend to the interlobar
fissures [102]. Chronic fibrosis leads to pulmonary volume
loss. Other pulmonary IIPs could also be observed in the lung,
particularly in the PPFE spared areas [101].
Conclusions
IIPs diagnosis is currently based on a multidisciplinary ap-
proach, and HRCToffers a special contribution because some
patterns have been associated with specific IIPs. Consequent-
ly, radiologists should be more able to detect ILDs on HRCT
images.
According to the 2011 evidence-based guidelines [11], UIP
can be diagnosed by HRCT when all criteria are fulfilled.
Early recognition of its pattern represents a diagnostic chal-
lenge for radiologists, in order to suggest correct disease
management (based on recent medical treatment such as
pirfenidone).
The overlap of imaging features among interstitial pneu-
monia limits the diagnosis. NSIP's diagnosis can be difficult
because of the heterogeneity of radiological appearances.
Smoking-related IIP patients could improve their course with
smoking cessation. Clinical presentation could help radiolo-
gists in their approach to acute/subacute IIDs (COP and AIP).
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